Misoprostol In the Prevention of Postpartum Hemorrhage
Academic International Journal of Medical Sciences · 2024
DOI: 10.59675/m125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic International Journal of Medical Sciences, 2024. Verfasst von Raakad kamel saadi und 3 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Misoprostol, an E1 prostaglandin analogue, induces uterine contractions. Because of this property, misoprostol has proven effective in preventing and treating postpartum haemorrhage (PPH) resulting from the failure of the uterus to contract fully after delivery. In this study, we tried to demonstrate the efficacy of misoprostol in preventing PPH. Patients and methods: we collected samples of 500 women who attended Al-Batool Teaching Hospital from July 2022 to January 2023. We collected the information by direct interview through a prepared written questionnaire. Results: 500 women were enrolled in the study, 4.8% had PPH despite the usage of misoprostol. All of them used the rectal route. We found a significant difference between the fibroid and the PPH (P < 0.001). Conclusion:There is a significantly lower incidence of PPH in misoprostol intake.
Zitieren
APA
saadi, R. K., Alobaidy, E. J., Mansoor, S. K., & fadil, R. A. A. (2024). Misoprostol In the Prevention of Postpartum Hemorrhage. Academic International Journal of Medical Sciences. https://doi.org/10.59675/m125
Vancouver
saadi RK, Alobaidy EJ, Mansoor SK, fadil RAA. Misoprostol In the Prevention of Postpartum Hemorrhage. Academic International Journal of Medical Sciences. 2024. doi:10.59675/m125
BibTeX
@article{saadi2024,
author = {saadi, Raakad kamel and Alobaidy, Enas Jaleel and Mansoor, Shayamaa Kanaan and fadil, Russul Abd Al_jabar},
title = {Misoprostol In the Prevention of Postpartum Hemorrhage},
journal = {Academic International Journal of Medical Sciences},
year = {2024},
doi = {10.59675/m125}
}
EUVIMED